Inductively powering a minimally invasive heart pump
感应式为微创心脏泵供电
基本信息
- 批准号:9201810
- 负责人:
- 金额:$ 14.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:AbdomenAdverse eventAffectAssisted CirculationAutomobile DrivingBlood flowBody TemperatureBreathingCaliberCaringCathetersClinical TrialsDataDependenceDescending aortaDevelopmentDevicesDiagnosisEdemaElectricityEnergy TransferFluid overloadFreezingGoalsHeartHeart failureHeatingHospitalsImplantInfectionKidneyLeadLegal patentMarketingMeasuresMechanicsOperative Surgical ProceduresPacemakersPatientsPerformancePerfusionPharmaceutical PreparationsPopulationPumpQuality of lifeReportingResearchRiskSheepSkinStagingSupport SystemSurfaceSyndromeSystemTechnologyTelemetryTemperatureTestingThoracotomyTranslatingWireless Technologyblood pumpclinical practicecostdesignexperienceimprovedmagnetic fieldminimally invasivenoveloperationphase 1 studyphase 2 studyphase 3 studypre-clinicalproduct development
项目摘要
Heart failure affects over 6 million people in the US alone. Every year, 660,000 new cases are diagnosed with
a cost approaching $35 billion. For 2 million of these patients (US), drugs can no longer control the problem
and mechanical support for blood flow is the most accessible treatment. However, heart pumps need power,
and percutaneous leads used today remain a significant cause of adverse events. We propose eliminating the
percutanous lead by using wireless power transfer.
Millar (Houston, TX) has develped the technology (US14/432,120) to receive electrical power from a coil inside
the body from a magnetic field generated from a coil located outside the body. Our research aim is to show
how the merging of the wireless power technology with the Procyrion (Houston, TX) Aortix heart pump can
eliminate the risk of percutaneous driveline infections.
We will measure the heat generated by the wireless power system when delivering 5W of power over a
variable distance of up to 20mm separation between external and implanted coils. This power level is adequate
for full pump operation and recharging an internal (short-term) battery.
Our long-term goal is make the Aortix the preferred treatment option for stage III HF patients
心力衰竭仅在美国就影响了600多万人。每年有660,000例新病例被诊断为
成本接近350亿美元。对于其中的200万患者(美国),药物已无法控制问题
对血流的机械支持是最容易获得的治疗方法。然而,心脏泵需要动力,
并且目前使用的经皮导线仍然是不良事件的重要原因。我们建议取消
通过使用无线功率传输的经皮电极导线。
Millar(Houston,TX)已经开发了从内部线圈接收电力的技术(US 14/432,120
所述身体不受由位于身体外部的线圈产生的磁场的影响。我们的研究目的是为了证明
无线供电技术与Procyrion(德克萨斯州休斯顿)Aortix心脏泵的合并如何能够
消除经皮传动系统感染的风险。
我们将测量无线电源系统在通过一个
外部线圈和植入线圈之间的距离可变,最多可达20 mm。这个功率水平是足够的
用于全泵运行和内部(短期)电池充电。
我们的长期目标是使Aortix成为III期HF患者的首选治疗选择
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BOB L PAULY其他文献
BOB L PAULY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 14.95万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 14.95万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 14.95万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 14.95万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 14.95万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 14.95万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 14.95万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 14.95万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 14.95万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 14.95万 - 项目类别: